Nivolumab-induced myositis: A case report and a literature review

J Neurol Sci. 2018 Apr 15:387:51-53. doi: 10.1016/j.jns.2018.01.030. Epub 2018 Feb 3.
No abstract available

Keywords: Anti PD1; Immune checkpoint inhibitors; Immune related adverse effects; Myositis; Nivolumab.

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adenocarcinoma / drug therapy
  • Aged
  • Antigens, CD / metabolism
  • Antineoplastic Agents, Immunological / adverse effects*
  • Electromyography
  • Humans
  • Lung Neoplasms / drug therapy
  • Male
  • Muscle, Skeletal / pathology
  • Myositis / chemically induced*
  • Nivolumab / adverse effects*

Substances

  • Antigens, CD
  • Antineoplastic Agents, Immunological
  • Nivolumab